MedTrace Logo

Paracetamol With Caffeine to Treat Episodic Tension Type Headache

NCT01755702 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2015-03-27

Study results available
· View outcomes & findings →

Summary

This study will compare a fast-absorbing paracetamol plus caffeine formula with placebo and an over-the-counter dose of paracetamol and ibuprofen to treat episodic tension headache.

Conditions

  • Headache, Tension-Type

Interventions

DRUG

Placebo

Placebo

DRUG

Experimental paracetamol + caffeine formulation

experimental paracetamol + caffeine formulation

DRUG

ibuprofen marketed formulation

ibuprofen marketed formulation

DRUG

Paracetamol marketed formulation

Paracetamol marketed formulation

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01755702 on ClinicalTrials.gov